Sanjeev Nanda, a British-Indian entrepreneur based in Dubai has invested in ISHVAN Pharmaceuticals Ltd to develop the pharmaceutical infrastructure of Russia. The company will focus on bringing in inexpensive and innovative medical drugs and devices to new pharmaceutical markets. Cipla, Laurus, and Myla are some of the Indian companies that have entered into negotiations with ISHVAN for this initiative.
Subscribe to:
Post Comments (Atom)
-
Darren Huston says that ten years from now, no paper work will be involved in the travel. “You’ll have no passport, no credit cards, no conf...
-
Founder & CEO Sachin Dev Duggal Engineer.ai – a tech icon globally, Sachin Dev Duggal, the Chief Wizard of Engineer.ai, was recognized w...
-
China has been unkind to the U.S. Internet giants Google, Facebook and Amazon.com. But as a growing China spurs demand for foreign...
No comments:
Post a Comment